The global burden of digestive tract tumors is profound, with these cancers accounting for nearly half of all malignant tumors worldwide.
Pharmalittle: German regulator eyes Ozempic export ban amid shortages; NIH-funded clinical trials lagging pharma’s in enrollment
Good morning, everyone, and how are you today? We are doing just fine, thank you. Given that this is already the middle of the week